Emil Lou
University of Minnesota-Twin Cities
H-index: 37
North America-United States
Top articles of Emil Lou
The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs)
2023/6/1
Real-world analysis of insurance status and survival in patients with selected GI cancers
Cancer Research
2024/3/22
Brooke Patterson
H-Index: 10
Emil Lou
H-Index: 24
Comprehensive molecular and immunological characterization of early-onset esophagogastric cancer
EBioMedicine
2019/2/1
AI enabled whole exome/transcriptome liquid biopsy addressing MCED, MRD, and therapy selection on a single platform
Liver
2024/3/22
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
Molecular Therapy Oncology
2024/3/21
Tunneling nanotubes and tumor microtubes—Emerging data on their roles in intercellular communication and pathophysiology: Summary of an International FASEB Catalyst Conference …
2024/3/15
Emil Lou
H-Index: 24
Frank Winkler
H-Index: 21
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
European Journal of Cancer
2024/2/10
Hiroyuki Arai
H-Index: 15
Yan Yang
H-Index: 13
Joshua Millstein
H-Index: 16
Federico Innocenti
H-Index: 33
Jingyuan Wang
H-Index: 16
Francesca Battaglin
H-Index: 17
Priya Jayachandran
H-Index: 10
Wu Zhang
H-Index: 31
Emil Lou
H-Index: 24
Benjamin A Weinberg
H-Index: 11
John Marshall
H-Index: 3
Sanjay Goel
H-Index: 15
Heinz-Josef Lenz
H-Index: 72
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer
JAMA Network Open
2024/2/5
Emil Lou
H-Index: 24
Axel Svedbom
H-Index: 19
LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).
2024/1/20
Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI …
2024/1/20
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
2024/1/20
Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC).
2024/1/20
High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or …
2024/1/20
Genomics and transcriptomics of pancreatic adenosquamous carcinoma.
2024/1/20
Sanjay Goel
H-Index: 15
Emil Lou
H-Index: 24
Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma.
2024/1/20
APC as a high-utility mutational biomarker that may identify subpopulations of patients with mutant RAS/BRAF and right-sided colorectal cancer (CRC) who derive …
2024/1/20
Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset.
2024/1/20
Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status
ESMO Gastrointestinal Oncology
2024/6/1
Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations
Journal of Experimental & Clinical Cancer Research
2022/4/2
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value
Journal for Immunotherapy of Cancer
2024
Francesca Battaglin
H-Index: 17
Joshua Millstein
H-Index: 16
Yan Yang
H-Index: 13
Hiroyuki Arai
H-Index: 15
Jingyuan Wang
H-Index: 16
Federico Innocenti
H-Index: 33
Priya Jayachandran
H-Index: 10
Annika Lenz
H-Index: 3
Wu Zhang
H-Index: 31
Evanthia Roussos Torres
H-Index: 13
Emil Lou
H-Index: 24
Benjamin A Weinberg
H-Index: 11
Heinz-Josef Lenz
H-Index: 72